Arena Pharmaceuticals Inc

NASDAQ:ARNA  
67.05
+0.65 (+0.98%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)4.11B
Current PEN/A
Forward PE N/A
2yr Forward PE N/A
See more stats
Estimates Current Quarter
Revenue$0.74 Million
Adjusted EPS-$2.20
See more estimates
10-Day MA$64.90
50-Day MA$64.33
200-Day MA$72.19
See more pivots

Arena Pharmaceuticals Inc Stock, NASDAQ:ARNA

6154 Nancy Ridge Drive, San Diego, California 92121-9604
United States of America
Phone: +1.858.453.7200
Number of Employees: 363

Description

Arena Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the discovery, development, and commercialization of novel drugs that target G protien-coupled receptors. It offers drugs for treatment in the field of cardiovascular, central nervous system, inflammatory, and metabolic diseases. The company was founded by Dominic P. Behan and Jack Lief on April 14, 1997 and is headquartered in San Diego, CA.